Ironwood Pharmaceuticals (IRWD) Total Liabilities (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Total Liabilities of $434.6 million for Q1 2026, up 9.49% sequentially from $396.9 million in Q4 2025, and up 32.81% YoY from $327.2 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Total Liabilities (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Total Liabilities for 17 years, with the latest figure at $434.6 million in Q1 2026.
- Quarterly Total Liabilities rose 32.81% year-over-year to $434.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $434.6 million (up 32.81% YoY) and the FY2025 annual result came in at $396.9 million, up 13.11% from the prior year.
- Total Liabilities grew to $434.6 million in Q1 2026 per IRWD's latest filing, from $396.9 million in the prior quarter.
- Over five years, Total Liabilities peaked at $1.2 billion in Q1 2023 and troughed at $327.2 million in Q1 2025.
- A 5-year average of $613.3 million and a median of $438.8 million in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities jumped 80.76% in 2022, then plunged 62.02% in 2024.
- Over 5 years, Total Liabilities stood at $1.1 billion in 2022, then tumbled by 57.2% to $471.1 million in 2023, then retreated by 25.51% to $350.9 million in 2024, then rose by 13.11% to $396.9 million in 2025, then advanced by 9.49% to $434.6 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $434.6 million, $396.9 million, and $396.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Ironwood Pharmaceuticals | 669.95 Mn | 590.82 Mn | - | 446.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 446.97 Mn |
| Mar 31, 2026 | 434.57 Mn |
| Dec 31, 2025 | 396.90 Mn |
| Sep 30, 2025 | 396.06 Mn |
| Jun 30, 2025 | 342.95 Mn |
| Mar 31, 2025 | 327.21 Mn |
| Dec 31, 2024 | 350.91 Mn |
| Sep 30, 2024 | 389.52 Mn |
| Jun 30, 2024 | 395.62 Mn |
| Mar 31, 2024 | 438.82 Mn |
| Dec 31, 2023 | 471.07 Mn |
| Sep 30, 2023 | 524.06 Mn |
| Jun 30, 2023 | 603.22 Mn |
| Mar 31, 2023 | 1.16 Bn |
| Dec 31, 2022 | 1.10 Bn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 975.69 Mn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | 1.13 Bn |
| Sep 30, 2021 | 1.08 Bn |